NOVEL ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION

NIH RePORTER · NIH · N43 · $297,245 · view on reporter.nih.gov ↗

Abstract

To support the development of novel HBV therapeutics.

Key facts

NIH application ID
10267592
Project number
75N93020C00044-0-9999-1
Recipient
CASTERBRIDGE PHARMACEUTICALS, INC.
Principal Investigator
BRUCE ROGERS
Activity code
N43
Funding institute
NIH
Fiscal year
2020
Award amount
$297,245
Award type
—
Project period
2020-08-21 → 2021-08-20